Clinical Trial Update: ALK Inhibitor in Metastatic Colorectal Cancer With ALK Mutation. [NA]

View source ↗

Summary

Clinical trial update for an ALK inhibitor in metastatic colorectal cancer with an ALK mutation; trial status is not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: Colorectal Cancer | NA | Status: UNKNOWN